NanoString Technologies (NSTG) BidaskScore is downgraded to Bought

NanoString Technologies

The BidaskScore of NanoString Technologies NSTGNSTG shows that the shares of the company are now NSTGStrongly Bought Bought by investors.

The BidaskScore of the Life Sciences Tools & ServicesLife Sciences Tools & Services shows that the sector is Life Sciences Tools & ServicesStrongly Bought Bought since March 13.

Here are the BidAskScore of other related companies in the Life Sciences Tools & Services sector:

NanoString Technologiesˌ Inc. provides life science tools for translational research and molecular diagnostic products. It specializes in the developmentˌ manufactureˌ and sale of biologic information from minute amounts of tissue. It offers nCounter Analysis System which directly profiles hundreds of molecules simultaneously using a novel barcoding technology to researchers in academicˌ governmentˌ and biopharmaceutical laboratories for use in understanding fundamental biology and the molecular basis of disease and to clinical laboratories and medical centers for diagnostic use. It also provides Prosigna Breast Cancer Assay which is a molecular diagnostic product that provides an assessment of a patientʿs risk of recurrence for breast cancer. The company was founded by Amber Ratcliffeˌ Krassen Dimitrovˌ and Dwayne Dunaway on June 20ˌ 2003 and is … read more

NanoString Technologies

Launched in 2016, the BidAskClubBidaskClub allows users to follow the evolution of the US equity market. BidaskClub provides a platform to create portfolios and be informed when a company´s or sector’s BidaskScore changes. BidaskClub is provided by LuxFinAdviceLuxFinAdvice.